Vinod A Pullarkat (Vinod Pullarkat)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 46

Top Topics

Acute Myeloid Leukemia

Newly Diagnosed

Tyrosine Kinase

Hematopoietic Stem Cell

Top Venues

American journal of hematology

Leukemia & lymphoma

Open forum infectious diseases

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Tamer Othman, Shanpeng Li, Jianying Zhang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Firoozeh Sahebi, Karamjeet Sandhu, Ricardo Spielberger, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Matthew G Mei, Ibrahim Aldoss, Paul B Koller
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology 99 (8) (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology 99 (8) (2024)
Tamer Othman, Paul B Koller, Ni-Chun Tsai, Dongyun Yang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Ricardo Spielberger, Firoozeh Sahebi, Monzr M Al Malki, Ji-Lian Cai, Karamjeet S Sandhu, Joshua Mansour, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Shukaib Arslan, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Ibrahim Aldoss, Matthew G Mei
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Tamer Othman, Paul B Koller, Ni-Chun Tsai, Dongyun Yang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Ricardo Spielberger, Firoozeh Sahebi, Monzr M Al Malki, Ji-Lian Cai, Karamjeet S Sandhu, Joshua Mansour, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Shukaib Arslan, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Ibrahim Aldoss, Matthew G Mei
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology 99 (9) (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology (2024)
Tamer Othman, Shanpeng Li, Jianying Zhang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Firoozeh Sahebi, Karamjeet Sandhu, Ricardo Spielberger, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Matthew G Mei, Ibrahim Aldoss, Paul B Koller
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology (2024)
Tamer Othman, Shanpeng Li, Jianying Zhang, Hoda Z Pourhassan, Vaibhav Agrawal, Dat Ngo, Jason Chen, Leonardo Farol, Firoozeh Sahebi, Karamjeet Sandhu, Ricardo Spielberger, Guido Marcucci, Stephen J Forman, Anthony S Stein, Ryotaro Nakamura, Vinod A Pullarkat, Matthew G Mei, Ibrahim Aldoss, Paul B Koller
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia. American journal of hematology 99 (8) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology 99 (8) (2024)
Justine Abella Ross, Brian Lee, Huiyan Ma, Bernard Tegtmeier, Deepa Nanayakkara, Jana K Dickter, Ricardo Spielberger, Eileen Smith, Vinod A Pullarkat, Stephen J Forman, Randy A Taplitz, Ryotaro Nakamura, Monzr M Al Malki, Sanjeet Singh Dadwal
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection. Open forum infectious diseases 11 (8) (2024)
Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley, Evan C Chen, Jorge Ramos, Anthony Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Sylvain Garciaz, Brian J Ball, Maximilian Stahl
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study. American journal of hematology 99 (8) (2024)
Justine Abella Ross, Brian Lee, Huiyan Ma, Bernard Tegtmeier, Deepa Nanayakkara, Jana K Dickter, Ricardo Spielberger, Eileen Smith, Vinod A Pullarkat, Stephen J Forman, Randy A Taplitz, Ryotaro Nakamura, Monzr M Al Malki, Sanjeet Singh Dadwal
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection. Open forum infectious diseases 11 (8) (2024)
Michael Rainone, Saro Kasparian, Tina Nguyen, Neel Talwar, Yuan Yuan, Matthew Mei, Joanne E Mortimer, James R Waisman, Niki Patel, Vinod A Pullarkat
Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates. The oncologist (2023)
Vaibhav Agrawal, Lindsey Murphy, Hoda Z Pourhassan, Vinod A Pullarkat, Ibrahim Aldoss
Optimizing CAR-T cell therapy in adults with B-cell acute lymphoblastic leukemia. European journal of haematology (2023)
Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Z Pourhassan, Vaibhav Agrawal, Paul Koller, Shukaib Arslan, Vanina Tomasian, Monzr M Al Malki, Andrew Artz, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S Sandhu, Brian J Ball, Salman Otoukesh, Idoroenyi Amanam, Pamela S Becker, Forrest M Stewart, Peter Curtin, Eileen Smith, Milhan Telatar, Anthony S Stein, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Vinod A Pullarkat
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. American journal of hematology (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology 98 (4) (2023)
Ibrahim Aldoss, Michelle Afkhami, Dongyun Yang, Zhaohui Gu, Sally Mokhtari, Shilpa Shahani, Hoda Z Pourhassan, Vaibhav Agrawal, Paul B Koller, Shukaib Arslan, Vanina Tomasian, Monzr M Al Malki, Andrew Artz, Amandeep Salhotra, Haris Ali, Ahmed Aribi, Karamjeet S Sandhu, Brian J Ball, Salman Otoukesh, Idoroenyi Amanam, Pamela S Becker, Forrest M Stewart, Peter Curtin, Eileen Smith, Milhan Telatar, Anthony S Stein, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Vinod A Pullarkat
High Response Rates and Transition to Transplant after Novel Targeted and Cellular Therapies in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia with Philadelphia-Like Fusions. American journal of hematology (2023)
Michael Rainone, Carolyn E Behrendt, Saro Kasparian, Tina Nguyen, Mina S Sedrak, Sayeh Lavasani, Daphne B Stewart, Yuan Yuan, Joanne E Mortimer, James R Waisman, Niki Patel, Vinod A Pullarkat
HER2-targeted antibody-drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia. Breast cancer (Tokyo, Japan) (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology 98 (4) (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus-specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis. American journal of hematology 98 (4) (2023)
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, Dongyun Yang, Qiao Zhou, Ketevan Gendzekhadze, Teodora Kaltcheva, Wasima Rida, Shannon Dempsey, Shukaib Arslan, Andrew Artz, Brian J Ball, Liana Nikolaenko, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond
Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis. American journal of hematology (2023)
Dat Ngo, Salman Otoukesh, Anthony S Stein, Stephen J Forman, Vinod A Pullarkat, Ibrahim Aldoss
The safety of concurrent intrathecal chemotherapy during blinatumomab in adults with acute lymphoblastic leukemia. Leukemia & lymphoma 63 (11) (2022)
Brian J Ball, Shukaib Arslan, Paul Koller, Dat Ngo, Michelle Afkhami, Amandeep Salhotra, Monzr M Al Malki, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Salman Otoukesh, Idoroenyi Amanam, Hoda Z Pourhassan, Andrew S Artz, Peter Curtin, Anthony Stein, Ryotaro Nakamura, Guido Marcucci, Eileen Smith, Vinod A Pullarkat, Ibrahim Aldoss
Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Leukemia & lymphoma (2022)
Corinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, Ketevan Gendzekhadze, Qiao Zhou, Katelyn Faircloth, Teodora Kaltcheva, Daisy Johnson, Sandra Ortega Francisco, Idoroenyi Amanam, Salman Otoukesh, Vinod A Pullarkat, Ryotaro Nakamura, Don J Diamond, Stephen J Forman, Monzr M Al Malki
Adoptive transfer of functional SARS-COV-2-specific immunity from donor graft to hematopoietic stem cell transplant recipients. American journal of hematology 97 (11) (2022)
Idoroenyi Amanam, Dat Ngo, Vinod A Pullarkat, Ibrahim Aldoss
Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Leukemia & lymphoma (2022)
Daniel A Pollyea, Keith W Pratz, Andrew H Wei, Vinod A Pullarkat, Brian A Jonas, Christian Recher, Sunil Babu, Andre C Schuh, Monique Dail, Yan Sun, Jalaja Potluri, Brenda J Chyla, Courtney D D DiNardo
Outcomes in Patients With Poor-risk Cytogenetics With or Without TP53 Mutations Treated With Venetoclax and Azacitidine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Hoda Z Pourhassan, Dongyun Yang, Michelle Afkhami, Raju Pillai, Brian J Ball, Monzr M Al Malki, Amandeep Salhotra, Haris Ali, Andrew Artz, Peter Curtin, Saro Armenian, Anthony Stein, Stephen J Forman, Guido Marcucci, Vinod A Pullarkat, Ryotaro Nakamura, Ibrahim Aldoss
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia. American journal of hematology 97 (5) (2022)
Hoda Z Pourhassan, Young Kim, Vinod A Pullarkat
Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia. European journal of haematology (2022)
Vaibhav Agrawal, Amandeep Salhotra, Joo Song, Zhaohui Gu, Anthony S Stein, Guido Marcucci, Stephen J Forman, Vinod A Pullarkat, Ibrahim Aldoss
The feasibility of additional CD19-targeted cellular therapy in relapsed/refractory B-ALL with re-emergence of CD19 antigen after prior CD19-negative relapse. American journal of hematology (2022)
Ibrahim Aldoss, Samer K Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R Wagner, Mary C Clark, Jennifer Simpson, Jinny Paul, Vibhuti Vyas, Sheng-Hsuan Chien, Anthony S Stein, Vinod A Pullarkat, Amandeep Salhotra, Monzr M Al Malki, Sandra H Thomas, L Elizabeth Elizabeth Budde, Guido Marcucci, Christine E Brown, Stephen J Forman
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Amandeep Salhotra, Dongyun Yang, Sally Mokhtari, Susanta Hui, Monzr M Al Malki, Saro H Armenian, Brianna Sigala, Ibrahim Aldoss, Vinod A Pullarkat, Stephen J Forman, Guido Marcucci, Ryotaro Nakamura, Andrew S Artz, Jeffery Wong, Anthony S Stein
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation. Leukemia & lymphoma (2021)
Amandeep Salhotra, Ahmed Aribi, Dat Ngo, Jianying Zhang, Karamjeet Sandhu, Monzr Al-Malki, Haris Ali, Paul B Koller, Shukaib Arslan, Elizabeth Budde, Samer Khaled, Sanjeet Dadwal, David S Snyder, Andrew Artz, Stephen Forman, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Ibrahim Aldoss, Vinod A Pullarkat
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351). American journal of hematology 96 (6) (2021)
Tamer A Othman, Matthew G Mei, Jianying Zhang, Ibrahim Aldoss, Anthony Stein, Stephen J Forman, Guido Marcucci, Vinod A Pullarkat
Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents. American journal of hematology 96 (5) (2021)
Maro Ohanian DO, Jose A Cancelas, Robertson Davenport, Vinod A Pullarkat, Tor Hervig, Catherine M Broome, Kelly Marek, Mary Kelly, Zartash Gul, Neeta Rugg, Shawnagay Nestheide, Bridget Kinne, Zbigniew Szczepiorkowski, Hagop Kantarjian, Joan Pehta, Ruth Biehl, Anna Yu, Fleur Aung, Ben Antebi, Glen Michael Fitzpatrick
Freeze-Dried Platelets Are a Promising Alternative in Bleeding Thrombocytopenic Patients with Hematological Malignancies. American journal of hematology (2021)
Salman Otoukesh, Joo Y Song, Mona Mojtahedzadeh, Sally Mokhtari, Guido Marcucci, Vinod A Pullarkat, Haris Ali
Refractory primary autoimmune myelofibrosis treated with ruxolitinib. American journal of hematology 96 (8) (2021)
Celalettin Ustun, Elizabeth A Morgan, Ethan M Ritz, Hanne Vestergaard, Sheeja Pullarkat, Philip M Kluin, Robert Ohgami, Linda B Baughn, Young Kim, Nam K Ku, David Czuchlewski, Michael Boe Møller, Ana-Iris Schiefer, Krzysztof Mrózek, Hans-Peter Horny, Tracy I George, Thomas Kielsgaard Kristensen, Todd Beck, Sunita Nathan, Cecilia Arana Yi, Cecilia Yeung, Vinod A Pullarkat, Jason Gotlib, Cem Akin, Jessica Kohlschmidt, Amandeep Salhotra, Lorinda Soma, Dong Chen, Se Y Han, Christina Cho, Wolfgang R Sperr, Sigurd Broesby-Olsen, Michael A Linden, Michelle Dolan, Gregor Hoermann, Jason L Hornick, Clara Bloomfield, Ryo Nakamura, H Joachim Deeg, Mark R Litzow, Gautam Borthakur, Daniel Weisdorf, Gerwin Huls, Miguel-Angel Perales, Peter Valent, Guido Marcucci
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure. International journal of laboratory hematology 43 (1) (2020)
Shukaib Arslan, Jianying Zhang, Prajwal Dhakal, Jenna Moran, Nuthana Naidoo, Jennifer Lombardi, Vinod A Pullarkat, Anthony S Stein, Guido Marcucci, George Yaghmour, Vijaya R Bhatt, Amir T Fathi, Ibrahim Aldoss
Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. American journal of hematology 96 (3) (2020)
Ibrahim Aldoss, Jianying Zhang, Matthew Mei, Monzr M Al Malki, Shukaib Arslan, Dat Ngo, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Amandeep Salhotra, Paul B Koller, Samer Khaled, Andrew Artz, David Snyder, Ryotaro Nakamura, Stephen J Forman, Anthony S Stein, Guido Marcucci, Vinod A Pullarkat
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia. American journal of hematology (2020)
Daniel A Pollyea, Keith Pratz, Anthony Letai, Brian A Jonas, Andrew H Wei, Vinod A Pullarkat, Marina Y Konopleva, Michael J Thirman, Martha Arellano, Pamela S Becker, Brenda Chyla, Wan-Jen Hong, Qi Jiang, Jalaja Potluri, Courtney D D DiNardo
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study. American journal of hematology 96 (2) (2020)
Ibrahim Aldoss, Dongyun Yang, Raju Pillai, James F Sanchez, Matthew Mei, Ahmed Aribi, Haris Ali, Karamjeet Sandhu, Monzr M Al Malki, Amandeep Salhotra, Samer Khaled, Weili Sun, Margaret O'Donnell, David Snyder, Ryotaro Nakamura, Anthony S Stein, Stephen J Forman, Guido Marcucci, Vinod A Pullarkat
Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia. American journal of hematology 94 (10) (2019)
Matthew Mei, Ibrahim Aldoss, Guido Marcucci, Vinod A Pullarkat
Hypomethylating agents in combination with venetoclax for acute myeloid leukemia: Update on clinical trial data and practical considerations for use. American journal of hematology 94 (3) (2018)
Ibrahim Aldoss, Joo Song, Tracey Stiller, Tina Nguyen, Joycelynne Palmer, Margaret O'Donnell, Anthony S Stein, Guido Marcucci, Stephen Forman, Vinod A Pullarkat
Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia. American journal of hematology 92 (9) (2017)